- $912.58m
- $1.06bn
- $529.97m
- 87
- 37
- 99
- 88
Annual income statement for Allient, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 367 | 404 | 503 | 579 | 530 |
| Cost of Revenue | |||||
| Gross Profit | 109 | 121 | 157 | 184 | 166 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 344 | 377 | 471 | 536 | 500 |
| Operating Profit | 23 | 26 | 31.7 | 42.3 | 30 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 18.8 | 23.1 | 23.7 | 29.7 | 16.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.6 | 24.1 | 17.4 | 24.1 | 13.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.6 | 24.1 | 17.4 | 24.1 | 13.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 13.6 | 24.1 | 17.4 | 24.1 | 13.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.976 | 1.72 | 1.24 | 1.69 | 0.907 |
| Dividends per Share |